Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1956 1
1957 1
1958 1
1962 1
1963 2
1966 6
1967 13
1968 9
1969 6
1970 13
1971 11
1972 13
1973 3
1974 9
1975 8
1976 10
1977 18
1978 6
1979 16
1980 11
1981 19
1982 38
1983 24
1984 20
1985 26
1986 45
1987 36
1988 31
1989 44
1990 37
1991 40
1992 28
1993 37
1994 51
1995 46
1996 46
1997 43
1998 53
1999 50
2000 49
2001 40
2002 37
2003 52
2004 54
2005 60
2006 62
2007 50
2008 71
2009 72
2010 53
2011 59
2012 54
2013 73
2014 59
2015 80
2016 79
2017 78
2018 80
2019 94
2020 104
2021 115
2022 96
2023 74

Text availability

Article attribute

Article type

Publication date

Search Results

2,327 results

Results by year

Filters applied: . Clear all
Page 1
MET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung Cancer.
Yoshida R, Saigi M, Tani T, Springer BF, Shibata H, Kitajima S, Mahadevan NR, Campisi M, Kim W, Kobayashi Y, Thai TC, Haratani K, Yamamoto Y, Sundararaman SK, Knelson EH, Vajdi A, Canadas I, Uppaluri R, Paweletz CP, Miret JJ, Lizotte PH, Gokhale PC, Jänne PA, Barbie DA. Yoshida R, et al. Among authors: shibata h. Cancer Res. 2022 Nov 2;82(21):4079-4092. doi: 10.1158/0008-5472.CAN-22-0770. Cancer Res. 2022. PMID: 36066413 Free PMC article.
TGF-β and Cancer Immunotherapy.
MaruYama T, Chen W, Shibata H. MaruYama T, et al. Among authors: shibata h. Biol Pharm Bull. 2022;45(2):155-161. doi: 10.1248/bpb.b21-00966. Biol Pharm Bull. 2022. PMID: 35110501 Free article. Review.
Effects of resistance training intensity on muscle quantity/quality in middle-aged and older people: a randomized controlled trial.
Otsuka Y, Yamada Y, Maeda A, Izumo T, Rogi T, Shibata H, Fukuda M, Arimitsu T, Miyamoto N, Hashimoto T. Otsuka Y, et al. Among authors: shibata h. J Cachexia Sarcopenia Muscle. 2022 Apr;13(2):894-908. doi: 10.1002/jcsm.12941. Epub 2022 Feb 20. J Cachexia Sarcopenia Muscle. 2022. PMID: 35187867 Free PMC article. Clinical Trial.
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019).
Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, Horio T, Hoshide S, Ikeda S, Ishimitsu T, Ito M, Ito S, Iwashima Y, Kai H, Kamide K, Kanno Y, Kashihara N, Kawano Y, Kikuchi T, Kitamura K, Kitazono T, Kohara K, Kudo M, Kumagai H, Matsumura K, Matsuura H, Miura K, Mukoyama M, Nakamura S, Ohkubo T, Ohya Y, Okura T, Rakugi H, Saitoh S, Shibata H, Shimosawa T, Suzuki H, Takahashi S, Tamura K, Tomiyama H, Tsuchihashi T, Ueda S, Uehara Y, Urata H, Hirawa N. Umemura S, et al. Among authors: shibata h. Hypertens Res. 2019 Sep;42(9):1235-1481. doi: 10.1038/s41440-019-0284-9. Hypertens Res. 2019. PMID: 31375757 Review. No abstract available.
Does first-line treatment have prognostic impact for unresectable HCC?-Atezolizumab plus bevacizumab versus lenvatinib.
Hiraoka A, Kumada T, Tada T, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Tsuji K, Ishikawa T, Tajiri K, Ochi H, Yasuda S, Toyoda H, Ogawa C, Nishimura T, Hatanaka T, Kakizaki S, Shimada N, Kawata K, Naganuma A, Kosaka H, Shibata H, Aoki T, Tanaka T, Ohama H, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Imai M, Koizumi Y, Nakamura S, Joko K, Iijima H, Kaibori M, Hiasa Y, Kudo M; Real-life Practice Experts for HCC (RELPEC) Study Group and HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan). Hiraoka A, et al. Among authors: shibata h. Cancer Med. 2023 Jan;12(1):325-334. doi: 10.1002/cam4.4854. Epub 2022 Jun 3. Cancer Med. 2023. PMID: 35666040 Free PMC article.
Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021.
Naruse M, Katabami T, Shibata H, Sone M, Takahashi K, Tanabe A, Izawa S, Ichijo T, Otsuki M, Omura M, Ogawa Y, Oki Y, Kurihara I, Kobayashi H, Sakamoto R, Satoh F, Takeda Y, Tanaka T, Tamura K, Tsuiki M, Hashimoto S, Hasegawa T, Yoshimoto T, Yoneda T, Yamamoto K, Rakugi H, Wada N, Saiki A, Ohno Y, Haze T. Naruse M, et al. Among authors: shibata h. Endocr J. 2022 Apr 28;69(4):327-359. doi: 10.1507/endocrj.EJ21-0508. Epub 2022 Apr 12. Endocr J. 2022. PMID: 35418526 Free article.
2023 update and perspectives.
Mogi M, Tanaka A, Node K, Tomitani N, Hoshide S, Narita K, Nozato Y, Katsurada K, Maruhashi T, Higashi Y, Matsumoto C, Bokuda K, Yoshida Y, Shibata H, Toba A, Masuda T, Nagata D, Nagai M, Shinohara K, Kitada K, Kuwabara M, Kodama T, Kario K. Mogi M, et al. Among authors: shibata h. Hypertens Res. 2023 Sep 15. doi: 10.1038/s41440-023-01398-5. Online ahead of print. Hypertens Res. 2023. PMID: 37710033 Review.
Dopamine-Secreting Pheochromocytoma and Paraganglioma.
Miyamoto S, Yoshida Y, Ozeki Y, Okamoto M, Gotoh K, Masaki T, Nishida H, Shibuya T, Shin T, Daa T, Mimata H, Kimura N, Shibata H. Miyamoto S, et al. Among authors: shibata h. J Endocr Soc. 2021 Oct 29;5(12):bvab163. doi: 10.1210/jendso/bvab163. eCollection 2021 Dec 1. J Endocr Soc. 2021. PMID: 34870059 Free PMC article. Review.
2,327 results